Skip to content

Clinical trials

Polycythemia Vera trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Not applicable Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20051
20062
20072
20081
20091
20101
20131
20171
20181
20242
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting5
Terminated4
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wake Forest University Health Sciences3
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
University of California, San Francisco2
Brigham and Women's Hospital1
Carmen Fava1
City of Hope Medical Center1
Duan Minghui1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera24
Primary Myelofibrosis19
Thrombocythemia, Essential18
Myeloproliferative Disorders15
Leukemia, Lymphocytic, Chronic, B-Cell11
Multiple Myeloma11
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Hodgkin Disease10
Leukemia10
Leukemia, Myelomonocytic, Chronic10

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.